Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit in Adults 40 to 65: Study! NetChatTVAugust 26, 2022COVID Drug, Medical News, Netchattv, News, Pfizer, Pharmaceuticals, Science news, US News, World News Post navigation PreviousNext August 26, 2022 Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit in Adults 40 to 65: Study https://t.co/boCaDaY3Lj via @epochtimes— NetChatTV (@NetChatTV) August 26, 2022 Share this:TwitterFacebookLike this:Like Loading... Related